NVS
$154.85
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Intraday
Recent News
Big drugmakers must face US overcharge claims on medications for low-income patients
By Jonathan Stempel March 17 (Reuters) - A U.S. appeals court on Tuesday revived a whistleblower lawsuit accusing four large drugmakers of defrauding the federal and state governments out of hundreds
Monte Rosa Therapeutics touts molecular glue pipeline, tees up GFORCE updates and Phase II plans
Monte Rosa Therapeutics (NASDAQ:GLUE) highlighted progress across its molecular glue degrader pipeline during a presentation at the Barclays 28th Annual Global Healthcare Conference, with Chief Medical Officer Filip Janku outlining upcoming clinical milestones in inflammation and immunology (I&I
Novartis Raises $11 Billion Bond to Fund $12 Billion Avidity Deal
Seven-tranche bond sale helps repay bridge loan tied to Avidity acquisition, amid $26 billion investment-grade issuance surge.
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks rose late Monday afternoon, with the NYSE Health Care Index up 0.8% and the State
Julius Baer’s $30 Million Pay Package Shows the Price of a Banking Reset
The Swiss private bank paid its new boss more than UBS chief Sergio Ermotti, highlighting how costly it can be to rebuild credibility after a major scandal